Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 27 results:
Author Title Type [ Year(Asc)]
Filters: Author is Morgan, C. L.  [Clear All Filters]
2018
C. L. Morgan, Qiao, Q., Grandy, S., Johnsson, K., Jenkins-Jones, S., Holden, S., and Currie, C. J., Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study, Diabetes Ther, vol. 9, pp. 269-283, 2018.
C. J. Currie, Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Voss, B., Rajpathak, S. N., Alemayehu, B., Peters, J. R., and Engel, S. S., Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival, Diabetes Obes Metab, vol. 20, pp. 821-830, 2018.
C. L. Morgan, Inzucchi, S. E., Puelles, J., Jenkins-Jones, S., and Currie, C. J., Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis, Diabetes Obes Metab, vol. 20, pp. 2140-2147, 2018.
T. R. Berni, Morgan, C. L., Berni, E. R., and Rees, D. A., Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes, J Clin Endocrinol Metab, vol. 103, pp. 2116-2125, 2018.
S. Jenkins-Jones, Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., and Ross, R. J. M., Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia, Eur J Endocrinol, vol. 178, pp. 309-320, 2018.
2014
C. J. Currie, Berni, E., Jenkins-Jones, S., Poole, C. D., Ouwens, M., Driessen, S., de Voogd, H., Butler, C. C., and Morgan, C. L., Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis, Bmj, vol. 349, p. g5493, 2014.
C. L. Morgan, Mukherjee, J., Jenkins-Jones, S., Holden, S. E., and Currie, C. J., Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study, Diabetes Obes Metab, vol. 16, pp. 957-62, 2014.
C. A. Bannister, Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., Mukherjee, J., and Currie, C. J., Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls, Diabetes Obes Metab, vol. 16, pp. 1165-73, 2014.
C. L. Morgan, Mukherjee, J., Jenkins-Jones, S., Holden, S. E., and Currie, C. J., Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality, Diabetes Obes Metab, vol. 16, pp. 977-83, 2014.
C. L. Morgan, Puelles, J., Poole, C. D., and Currie, C. J., The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study, J Diabetes Complications, vol. 28, pp. 360-4, 2014.
C. A. Bannister, Poole, C. D., Jenkins-Jones, S., Morgan, C. L., Elwyn, G., Spasic, I., and Currie, C. J., External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations, Diabetes Care, vol. 37, pp. 537-45, 2014.
[Page last reviewed 6 September 2019]